On Monday, 27 January 2020, the entire AmCham EU secretariat visited the Dow site in Terneuzen, the Netherlands. The secretariat met some of the staff at the new Diamond Centre, toured the manufacturing plant and discussed many topics including inclusion and sustainability. It was incredibly valuable to understand the work of one of AmCham EU's member companies as well as being a highly interesting and educational visit.
AmCham EU visits member company's Dow site in the Netherlands
On Monday, 27 January 2020, the entire AmCham EU secretariat visited the Dow site in Terneuzen, the Netherlands. The secretariat met some of the staff at the new Diamond Centre, toured the manufacturing plant and discussed many topics including inclusion and sustainability. It was incredibly valuable to understand the work of one of AmCham EU's member companies as well as being a highly interesting and educational visit.
Dow Terneuzen is the second largest production site of The Dow Chemical Company in the world and the largest Dow site in the Benelux. The headquarters of the Benelux, one of the largest research departments of Dow Europe and the Dow Benelux integrated Center (DBIC) are also located in Terneuzen. The AmCham EU secretariat had the opportunitiy to learn about the processes by which the chemicals are created in order to produce plastics and were given presentations on cutting-edge thinking on sustainability solutions. Thank you to the team at Dow for hosting us and giving us insights that are very helpful for our work, and in particular to Anton van Beek, President of Dow Benelux and member of our Executive Council, as well as Eveline Kooiman, Kees Biesheuvel and Dennis Kredler.
Related items
:focal())
Position Paper
13 May 2026
Strengthening Europe’s cybersecurity framework through simplification
The review of the Cybersecurity Act (CSA 2.0) is an opportunity to build a more coherent, outcome-oriented EU cybersecurity framework. While the proposal recognises fragmentation across the Single Market, further simplification is needed to reduce overlaps and support effective compliance.
A harmonised approach to risk assessment and supervision can strengthen resilience while avoiding duplicative obligations. Certification and supply-chain measures should remain risk-based, objective, technical and aligned with international standards. Structured industry engagement and clear designation thresholds under the ICT Supply Chain Framework and a secure-by-design approach to policymaking will be essential to support cybersecurity and global interoperability. Read more on how CSA 2.0 can strengthen resilience across the Single Market.
:focal())
News
4 May 2026
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
News
4 May 2026
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.